LEXINGTON, Ky. (Dec. 5, 2011)—UK spinoff company Equinext is taking the first step to test its device to treat equine tendon and ligament injuries using funds raised entirely from local Kentucky investors. Equinext recently closed an $850,000 Series A investment round and started the initial work on their clinical trial with strategic partner Hagyard Equine Medical Institute.

Read full article on University of Kentucky Office for Commercialization & Economic Development